| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Operating expenses | ||||||
Research and development | ||||||
61,858 | 33,287 | 18,506 | 14,672 | |||
General and administrative | ||||||
29,560 | 12,434 | 3,748 | 2,388 | |||
Total operating expenses | ||||||
91,418 | 45,721 | 22,254 | 17,060 | |||
Loss from operations | ||||||
-91,418 | -45,721 | -22,254 | -17,060 | |||
Interest income, net | ||||||
6,201 | 2,375 | -1,302 | -51 | |||
Other income (expense), net | ||||||
-155 | -192 | -287 | 11 | |||
Loss before benefit from income taxes | ||||||
-85,372 | -43,538 | -23,843 | -17,100 | |||
Provision for (benefit from) income taxes | ||||||
0 | 0 | -291 | 0 | |||
Net loss | ||||||
-85,372 | -43,538 | -23,552 | -17,100 | |||
Unrealized gain on marketable securities, net of tax | ||||||
152 | -15 | 0 | 0 | |||
Comprehensive loss | ||||||
-85,220 | -43,553 | -23,552 | -17,100 | |||
Net loss per common share: | ||||||
Basic and diluted | ||||||
-1.89 | -2.20 | -14.54 | -13.03 | |||
Weighted-average number of common shares outstanding: | ||||||
Basic and diluted | ||||||
45,191 | 19,833 | 1,620 | 1,312 | |||